Kathleen Laporte - Net Worth and Insider Trading

Kathleen Laporte Net Worth

The estimated net worth of Kathleen Laporte is at least $1,332 dollars as of 2024-04-27. Kathleen Laporte is the Director of Bolt Biotherapeutics Inc and owns about 1,200 shares of Bolt Biotherapeutics Inc (BOLT) stock worth over $1,332. Kathleen Laporte is also the Director of 89bio Inc and owns about 0 shares of 89bio Inc (ETNB) stock worth over $0. Details can be seen in Kathleen Laporte's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Kathleen Laporte has not made any transactions after 2023-07-17 and currently still holds the listed stock(s).

Transaction Summary of Kathleen Laporte

To

Kathleen Laporte Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Kathleen Laporte owns 7 companies in total, including Precipio Inc (PRPO) , Affymax Inc (AFFY) , and Paratek Pharmaceuticals Inc (PRTK) among others .

Click here to see the complete history of Kathleen Laporte’s form 4 insider trades.

Insider Ownership Summary of Kathleen Laporte

Ticker Comapny Transaction Date Type of Owner
PRPO Precipio Inc 2018-08-07 director
AFFY Affymax Inc 2012-12-14 director
PRTK Paratek Pharmaceuticals Inc 2010-01-14 director
EHTH eHealth Inc 2006-10-12 director
BOLT Bolt Biotherapeutics Inc 2022-03-24 director
ETNB 89bio Inc 2023-07-17 director
PBAX Phoenix Biotech Acquisition Corp 2021-10-05 director

Kathleen Laporte Latest Holdings Summary

Kathleen Laporte currently owns a total of 2 stocks. Among these stocks, Kathleen Laporte owns 1,200 shares of Bolt Biotherapeutics Inc (BOLT) as of February 9, 2021, with a value of $1,332 and a weighting of 100%. Kathleen Laporte also owns 0 shares of 89bio Inc (ETNB) as of July 17, 2023, with a value of $0 and a weighting of 0%.

Latest Holdings of Kathleen Laporte

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
BOLT Bolt Biotherapeutics Inc 2021-02-09 1,200 1.11 1,332
ETNB 89bio Inc 2023-07-17 0 8.26 0

Holding Weightings of Kathleen Laporte


Kathleen Laporte Form 4 Trading Tracker

According to the SEC Form 4 filings, Kathleen Laporte has made a total of 1 transactions in Bolt Biotherapeutics Inc (BOLT) over the past 5 years, including 1 buys and 0 sells. The most-recent trade in Bolt Biotherapeutics Inc is the acquisition of 1,200 shares on February 9, 2021, which cost Kathleen Laporte around $24,000.

According to the SEC Form 4 filings, Kathleen Laporte has made a total of 1 transactions in 89bio Inc (ETNB) over the past 5 years, including 0 buys and 1 sells. The most-recent trade in 89bio Inc is the sale of 12,500 shares on July 17, 2023, which brought Kathleen Laporte around $235,000.

Insider Trading History of Kathleen Laporte

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Kathleen Laporte Trading Performance

GuruFocus tracks the stock performance after each of Kathleen Laporte's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Kathleen Laporte is -32.6%. GuruFocus also compares Kathleen Laporte's trading performance to market benchmark return within the same time period. The performance of stocks bought by Kathleen Laporte within 3 months outperforms 0 times out of 1 transactions in total compared to the return of S&P 500 within the same period.

You can select different timeframes to see how Kathleen Laporte's insider trading performs compared to the benchmark.

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Performance of Kathleen Laporte

Average Return

-90%

Average return per transaction

Outperforming Transactions

0%

0 out of 1 outperforming transactions.
Each transaction is measured over a period and compared to .
1 Month 3 Months 6 Months 1 Year 2 Years 3 Years
Return(%) 5.28 -32.6 -65.28 -90 -79.61 -68.2
Relative Return to S&P 500(%) 6.2 -40.82 -78.6 -107.28 -81.76 -76.92

Kathleen Laporte Ownership Network

Ownership Network List of Kathleen Laporte

No Data

Ownership Network Relation of Kathleen Laporte


Kathleen Laporte Owned Company Details

What does Precipio Inc do?

Who are the key executives at Precipio Inc?

Kathleen Laporte is the director of Precipio Inc. Other key executives at Precipio Inc include Chief Operations Officer Ahmed Zaki Sabet , director & Chief Executive Officer Ilan Danieli , and Chief Financial Officer Matthew Gage .

Precipio Inc (PRPO) Insider Trades Summary

Over the past 18 months, Kathleen Laporte made no insider transaction in Precipio Inc (PRPO). Other recent insider transactions involving Precipio Inc (PRPO) include a net purchase of 40,000 shares made by Richard A Sandberg , a net purchase of 16,500 shares made by Ilan Danieli , and a net purchase of 750 shares made by Ahmed Zaki Sabet .

In summary, during the past 3 months, insiders sold 0 shares of Precipio Inc (PRPO) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Precipio Inc (PRPO) were sold and 2,863 shares were bought by its insiders, resulting in a net purchase of 2,863 shares.

Precipio Inc (PRPO)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Precipio Inc Insider Transactions

No Available Data

Kathleen Laporte Mailing Address

Above is the net worth, insider trading, and ownership report for Kathleen Laporte. Currently GuruFocus does not have mailing address information for Kathleen Laporte.

Discussions on Kathleen Laporte

No discussions yet.